Spelling suggestions: "subject:"cd8"" "subject:"ad8""
61 |
The LCMV gp33-specific memory T cell repertoire narrows with ageBunztman, Adam, Vincent, Benjamin, Krovi, Harsha, Steele, Shaun, Frelinger, Jeffrey January 2012 (has links)
BACKGROUND:The memory response to LCMV in mice persists for months to years with only a small decrease in the number of epitope specific CD8 T cells. This long persistence is associated with resistance to lethal LCMV disease. In contrast to studies focused on the number and surface phenotype of the memory cells, relatively little attention has been paid to the diversity of TCR usage in these cells. CD8+ T cell responses with only a few clones of identical specificity are believed to be relatively ineffective, presumably due to the relative ease of virus escape. Thus, a broad polyclonal response is associated with an effective anti-viral CD8+ T cell response.RESULTS:In this paper we show that the primary CD8+ T cell response to the LCMV gp33-41 epitope is extremely diverse. Over time while the response remains robust in terms of the number of gp33-tetramer+ T cells, the diversity of the response becomes less so. Strikingly, by 26months after infection the response is dominated by a small number TCRbeta sequences. In addition, it is of note the gp33 specific CD8+ T cells sorted by high and low tetramer binding populations 15 and 22months after infection. High and low tetramer binding cells had equivalent diversity and were dominated by a small number of clones regardless of the time tested. A similar restricted distribution was seen in NP396 specific CD8+ T cells 26months after infection. The identical TCRVbeta sequences were found in both the tetramerhi and tetramerlo binding populations. Finally, we saw no evidence of public clones in the gp33-specific response. No CDR3 sequences were found in more than one mouse.CONCLUSIONS:These data show that following LCMV infection the CD8+ gp33-specific CD8 T cell response becomes highly restricted with enormous narrowing of the diversity. This narrowing of the repertoire could contribute to the progressively ineffective immune response seen in aging.
|
62 |
Characterization of bovine granzymes and studies of the role of granzyme B in killing of Theileria-infected cells by CD8+ T cellsYang, Jie January 2012 (has links)
Previous studies have shown that cytotoxic CD8+ T cells are important mediators of immunity against the bovine intracellular protozoan parasite T. parva. The present study set out to determine the role of granule enzymes in mediating killing of parasitized cells, first by characterising the granzymes expressed by bovine lymphocytes and, second, by investigating their involvement in killing of target cells. Experiments using the perforin inhibitor concanamycin A confirmed that CD8+ T cell killing of T. parva-infected cells is dependent on granule exocytosis, a process that involves release of granzymes into the target cell, resulting in activation of apoptotic pathways. Analysis of the bovine genome sequence identified orthologues of granzymes A, B, H, K and M, as well as another gene O, most closely related to granzyme A. The genes were found within 3 loci in the genome. Using specific PCR assays, all of these granzymes were shown to be expressed in Theileria-specific CD8+ T cells. Further studies were undertaken to study the role of granzyme B in killing. DNA constructs encoding functional and non-functional forms of bovine granzyme B were produced and the proteins expressed in COS cells were used to establish an enzymatic assay to detect and quantify expression of functional granzyme B protein. Using this assay, the levels of killing of different T. parvaspecific CD8+ T cell clones were found to be significantly correlating with levels of granzyme B protein expression. Moreover, the granzyme B inhibitor III, Z-IETDFMK was shown to inhibit killing by CD8+ T cell clones.
|
63 |
Caractérisation d'un modèle Murin B7.2 transgénique de démyélinisation spontanéeBrisebois, Marcel January 2006 (has links)
Le but du travail de recherche présenté dans cette thèse était de déterminer les mécanismes impliqués dans le développement de symptômes neurologiques observés dans une lignée de souris transgénique pour l’expression de la molécule B7.2/CD86. La molécule B7.2 est un des ligands du récepteur CD28 qui transmet des signaux intracellulaires nécessaires à la prolifération des lymphocytes T et au développement de leurs fonctions effectrices. Nos travaux démontrent que ces souris développent spontanément une pathologie démyélinisante auto-immune conséquemment à l’expression transgénique de la molécule B7.2 sur les cellules de la microglie du système nerveux central. Les souris affectées présentent une infiltration de lymphocytes T au niveau du système nerveux central et périphérique proximal et cet infiltrat est prédominé par une population de lymphocytes T CD8[indice supérieur +] mémoires/effectrices. Nos études indiquent que la population de lymphocytes T CD8[indice supérieur +] joue un rôle effecteur dans le développement de la pathologie tandis que la population des lymphocytes T CD4[indice supérieur +] la régulent de façon négative. Nos résultats démontrent également que l’activation des cellules de la microglie survient très tôt lors de la pathogenèse et que cette activation des cellules de la microglie ainsi que le processus de démyélinisation sont entièrement dépendants de la signalisation par le récepteur de l’IFNy. Ce modèle de démyélinisation reflète l’émergence de cellules T autoréactives spécifiques au système nerveux à partir d’un répertoire périphérique polyclonal, un processus immunopathogénique qui se produit possiblement durant la pathogenèse de la sclérose en plaques. De plus, il présente certaines caractéristiques pathologiques similaires à celles de la sclérose en plaques tels que le développement spontané du processus de démyélinisation et de dommages aux axones ainsi qu’une connexité avec l’activité de l’IFNy. Plusieurs données de la littérature suggèrent que les lymphocytes T CD8[indice supérieur +] pourraient jouer un rôle dans les maladies auto-immunes affectant le système nerveux, mais la contribution exacte et les mécanismes pathogéniques spécifiques des lymphocytes T CD8[indice supérieur +] ne sont pas encore clairement établis. Le travail de recherche présenté dans cette thèse a donc permis d’établir que la lignée de souris transgénique qui exprime de façon constitutive le ligand de costimulation B7.2/CD86 sur les cellules de la microglie représente un nouveau modèle animal qui permettra d’étudier et de comprendre ces mécanismes pathogéniques spécifiques aux lymphocytes T CD8[indice supérieur +] ainsi que les processus qui régulent la participation des lymphocytes T CD8[indice supérieur +] dans la destruction de la gaine de myéline.
|
64 |
Inhibition de la réception des signaux de danger via les TLR TRIF-dépendants dans les cellules dendritiques myéloïdes infectées avec le virus de l'hépatice C in vivo : mécanisme d'évasion de l'immunité innée dans l'infection chroniqueRodrigue-Gervais, Ian Gaël January 2008 (has links)
Thèse numérisée par la Division de la gestion de documents et des archives de l'Université de Montréal.
|
65 |
Identification of immunological targets for HIV-1 vaccine and cure strategiesHancock, Gemma January 2014 (has links)
HIV-1 chronically infected individuals represent a large disease burden, making the development of a therapeutic vaccine for use in chronic infection a priority. However, therapeutic vaccination has not been successful to date. Most approaches have employed viral vectored vaccines encoding full length viral proteins, which aimed to boost pre-existing CD8+ T cell responses by mimicking natural HIV-1 infection. Simply boosting these pre-existing CD8+ T cell responses which have previously failed to control the virus may be insufficient. Although HIV-1 has a huge capacity to diversify, certain regions are less tolerant of mutations due to structural and functional constraints. We therefore hypothesised that it would be necessary to redirect the immune response to more vulnerable regions of the proteome, such as conserved regions. HIVconsv is a rationally designed conserved region vaccine. Vaccination of 19 chronically HIV-1 infected HAART treated patients with MVA.HIVconsv was safe and well tolerated. There was a significant increase in the magnitude of HIVconsv-specific T cell response following vaccination (p = 0.001), as measured by IFN-γ Elispot assay, but changes observed in vaccinees did not reach statistical significance when compared with placebo recipients (p = 0.48). The capacity of CD8+ T cells to inhibit HIV-1 replication in vitro is highly predictive of virus control in vivo and is thus a possible surrogate of vaccine efficacy. There was a trend towards increased CD8+ T cell mediated inhibition following vaccination with 2x10<sup>8</sup>pfu MVA.HIVconsv (17% inhibition pre- vs 54% inhibition post-vaccination, p = 0.06). However, measurement of the latent HIV-1 reservoir by quantification of total HIV-1 DNA in circulating CD4+ T cells by droplet digital PCR showed no reduction in size upon vaccination, indicating CD8+ T cells induced by vaccination with MVA.HIVconsv were not of sufficient potency to impact the reservoir. In a second cohort of HIV-1 infected individuals, antiviral inhibitory activity was measured in 36 HIV-1-infected STEP and Phambili trial participants. Sustained potent CD8+ T cell antiviral inhibitory responses were rare but were strongly correlated with IFN-γ responses to so-called ‘beneficial’ low entropy regions in HIV-1 Gag and Pol, that had been reported previously to be associated with HIV-1 control, (r = 0.69, p = 0.0001). This correlation was still significant after controlling for protective HLA alleles, whereas responses to conserved elements were only weakly correlated with viral inhibition (r = 0.41, p = 0.04). These data indicate that immunogens that are based on the selection of regions within the viral proteome by conservation score alone may not induce the most effective HIV-1-specific T cell responses and they highlight the importance of systematically selecting specific regions associated with HIV-1 control, together with exclusion of immunodominant decoy epitopes.
|
66 |
Klonierung und Charakterisierung eines polymorphen MHC Kl. I-Moleküls der LEW.1F-Ratte, das präferentiell Va8.2-exprimierende CD8-T-Zellen expandiert / Cloning and characterization of a polymorphic MHC class I molecule of the LEW.1F rat, which preferentially expands Va8.2 positive CD8 T-cellsMehling, Beatrix January 2000 (has links) (PDF)
Der MHC der Lewis.1F-Ratte (RT1f) stimuliert die präferentielle Expansion von CD8-T-Zellen, die das V-Segment 8.2 (AV8S2) der TCR-alpha-Kette verwenden. Sowohl als Folge der positiven thymischen Selektion in der Lewis.1F-Ratte (LEW.1F) wie auch bei der RT1f-Alloerkennung. Es war Ziel dieser Arbeit, das MHC Kl. I-Molekül der LEW.1F-Ratte, das diese präferentielle Expansion von AV8S2-Zellen induziert, zu klonieren sowie die Kontaktpunkte der Interaktion zwischen dem MHC-Molekül und AV8S2 zu kartieren. Über RT-PCR wurde ein MHC-I-Gen der LEW.1F-Ratte (RT1.Af) isoliert, sequenziert und zusammen mit einem anderen MHC-I-Gen aus der LEW.1F-Ratte (A2f) analysiert, das von einer Arbeitsgruppe aus Babraham (Cambridge, UK) gefunden worden war. Durch einen Nukleotidsequenz-Vergleich von Af und A2f mit bekannten Ratte-MHC-I-Genen konnte gezeigt werden, daß die Sequenzen beider charakteristisch für Ratte-MHC-I-Gene sind. Beide Moleküle wurden stabil in L-Zellen, rCD80-transfizierte P815-Zellen und T-Zellhybridomen (THO35/1) exprimiert. Die serologische Charakterisierung mit 19 RT1f-reaktiven Alloantikörpern ergab, daß sich die LEW.1F-Serologie alleine durch Af erklären läßt. In einem Zytotoxizitätstest mit LEW.1F-reaktiven zytotoxischen T-Lymphozyten, wurde Af spezifisch erkannt, A2f dagegen nicht. Serologie und Zytotoxizitätstest zeigen, daß die RT1f-spezifische Alloerkennung das Af-Molekül fokussiert, A2f unbedeutend scheint. Möglicherweise, da dieses Molekül in der LEW.1F-Ratte nur schwach exprimiert ist. Die Interaktion von Af und A2f mit AV8S2-Zellen wurde mittels einer MLR (gemischte Lymphozytenreaktion) in der Alloerkennung untersucht: Af, nicht aber A2f, stimuliert die präferentielle Expansion AV8S2-positiver CD8-T-Zellen in der Alloreaktion. Somit ist Af als das Molekül identifiziert, daß die Überselektion von AV8S2-Zellen vermutlich auch in der thymischen Repertoire-Selektion induziert. Zur Kartierung der Af/AV8S2-Interaktion wurden Hybridmoleküle aus Aa und Af gentechnisch hergestellt: Aa und Af unterscheiden sich extrazellulär nur in sieben Aminosäuren, die konzentriert auf zwei Regionen des MHC-Moleküls liegen: "Region I" (AS 62, 63, 65, 69, 70) und "Region II" (167, 169). Aa stimuliert keine präferentielle AV8S2-Zell-Expansion, daher muß die charakteristische Kombination dieser sieben Aminosäuren für die präferentielle Interaktion mit AV8S2-positiven CD8-T-Zellen ausschlaggebend sein. Durch MLRs mit Hybrid-exprimierenden Stimulatorzellen wurde gezeigt, daß beide Regionen zur präferentiellen Expansion AV8S2-exprimierender CD8-T-Zellen beitragen. Durch den Vergleich mit anderen Daten unseres Labors konnte dargelegt werden, daß die beta-Kette zur präferentiellen Interaktion von AV8S2-Zellen mit Af keinen spezifischen Beitrag leistet. Ebenso unbeteiligt ist die Komplementarität-bestimmende Region 2 (CDR2) der alpha-Kette. Die charakteristischen Sequenzen von CDR1alpha und CDR3alpha dagegen sind für die präferentielle Expansion von AV8S2-positiven CD8-T-Zellen durch Af essentiell. / It was shown previously that RT1f (the MHC of the LEW.1F rat) preferentially expands AV8S2 (V-segment 8.2 of the TCR-alpha chain) expressing T-cells in positive thymic selection in the LEW.1F rat (overselection) as well as AV8S2 cells alloreactive to RT1f. As the preferential AV8S2 expansion was only detected in the CD8 T-cells, a MHC class I molecule of the LEW.1F rat was postulated to be responsible for the overselection. In this thesis the MHC I molecule of the LEW.1F rat promoting preferential expansion of AV8S2 CD8 T-cells in allorecognition was identified. To this end a MHC I molecule of the LEW.1F rat, Af, was cloned and sequenced. Together with A2f, another MHC I molecule of the LEW.1F rat, cloned and sequenced by a group from Babraham/UK, Af was expressed in various cell lines and hybridomas. The two molecules were tested for recognition by RT1f-reactive antibodies and cytotoxic T-lymphocytes. By these criteria Af was defined as a MHC class I molecule of the LEW.1F rat whereas A2f was not. The ability to overselect AV8S2 CD8 T-cells was examined by MLR (mixed lymphocyte reaction). Preferential interaction of this TCR segment with Af but not A2f has therefore been demonstrated. Thus Af is the molecule preferentially expanding AV8S2 cells. To identify the Af/AV8S2-contact points hybrids between Aa and Af were generated: Extracellularly, Aa differs from Af in only seven aminoacids, which are clustered in two different regions (region I and II). Yet Aa is not able to promote preferential expansion of AV8S2 CD8 T-cells. Therefore the specific combination of the seven aminoacids differing between the two molecules are crucial in the observed preferential AV8S2 reactivity of Af. In generating hybrids differing in these regions, equal contributions of both regions for recognition by AV8S2 RT1f-reactive CD8 T-cells could be demonstrated. By theoretical implication the Af/AV8S2 interaction points could be narrowed down further: On the side of the MHC, solely the presumably directly TCR-contacted MHC aminoacids 62, 65, 69 and 167 are likely to be involved in AV8S2-cell expansion. On TCR side, the beta-chain is not involved in specific Af interaction. Only complementarity determining regions 1 and 3 of the TCR-alpha chain are essential for preferential interaction with Af by AV8S2 positive CD8 T-cells.
|
67 |
The role of mononuclear cells in tuberculosisSussman, Garth 03 June 1992 (has links)
Thesis presented in fulfilment of the requirements governing the degree of Philosophy in the School of Medicine, University of the Witwatersrand. Johannesburg / Sonicates derived from Mycobacterium tuberculosis suppressed lymphocytes proliferation. Pulsing of monocytes with mycobacterial sonicates resulted in the release of high molecular weight lipids. Both these lipids and those prepared by column fractionation of mycobacterial sonicates suppressed lymphocyte blastogenesis.This effect was due to the activation and not the proliferation of CD8+ lymphocytes by the lipid containing mycobacterial fractions of Mr>200kDa that could be obtained in vitro by column fractions. / IT2018
|
68 |
Regulation of Alloreactive CD8 T Cell Responses by Costimulation and InflammationJangalwe, Sonal 30 June 2017 (has links)
CD8 T lymphocytes are a crucial component of the adaptive immune system and mediate control of infections and malignancy, but also autoimmunity and allograft rejection. Given their central role in the immune system, CD8 T cell responses are tightly regulated by costimulatory signals and cytokines. Strategies targeting signals that are critical for T cell activation have been employed in a transplantation setting to impede alloreactive T cell responses and prevent graft rejection. The goal of my thesis is to understand how costimulatory signals and inflammation regulate alloreactive CD8 T cell responses and how to target these pathways to develop more effective tools to prevent graft rejection.
Costimulation blockade is an effective approach to prolong allograft survival in murine and non-human primate models of transplantation and is an attractive alternative to immunosuppressants. I describe a novel murine anti-CD40 monoclonal antibody that prolongs skin allograft survival across major histocompatibility barriers and attenuates alloreactive CD8 T cell responses. I find that the pro-apoptotic proteins Fas and Bim function concurrently to regulate peripheral tolerance induction to allografts. Activation of the innate immune system by endogenous moIecules released during surgery or infections in transplant recipients can modulate T cell responses. However, the direct impact of inflammation on alloreactive CD8 T cell responses is not clear. Using a T cell receptor (TCR) transgenic mouse modeI, I demonstrate that inflammatory stimuli bacterial lipopolysaccharide (LPS) and the viral dsRNA mimetic poly(I:C) differentially regulate donor-reactive CD8 T cell responses by generating distinct cytokine milieus. Finally I demonstrate the role of pro-inflammatory cytokines stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) in improving human B cell development in humanized NOD-scid IL2Rγnull (NSG) mice.
|
69 |
CD8+ T Cell Dysfunction in Chronic HCV Infection and its Association with Liver FibrosisDeonarine, Felicia 28 March 2018 (has links)
Infection with hepatitis C virus (HCV) can cause liver damage known as fibrosis, which
often leads to liver disease and hepatocellular carcinoma. The impairment of circulating, bulk
(non-specific and specific) CD8+ T cells within HCV-infection, characterized by an altered
phenotype and the increased expression of pro-apoptotic genes, is observed when compared to
uninfected controls. The relationship between bulk CD8+ T cell function and the extent of liver
damage has not been demonstrated. In this study, widespread immune alterations were observed
in untreated HCV infection with advanced liver fibrosis. Untreated HCV-infected individuals
with advanced fibrosis possessed a significantly decreased proportion of naïve CD8+ T cells and
an increased proportion of late effector memory CD8+ T cells compared to uninfected controls.
Upon T cell receptor (TCR) stimulation, these individuals also had an increased intracellular
IFN-γ expression for four CD8+ T cell subsets, a decreased CD107a expression for central
memory CD8+ T cells, and a decreased perforin induction for naïve and central memory CD8+ T
cells. These immune alterations did not reverse 24 weeks after viral cure. This study indicates
there is a relationship between the differentiation and function of bulk CD8+ T cells and the
extent of liver damage within HCV infection.
|
70 |
Defining the immunological basis of cerebral pathology during murine experimental cerebral malaria and understanding the basis of infection induced resistanceShaw, Tovah January 2015 (has links)
Malaria affects 200 million people annually, resulting in 584,000 - 1,238,000 deaths. The majority of these deaths occur in children, less than 5 years of age, in sub-Saharan Africa and are due to cerebral malaria (CM), a neuropathology induced primarily by the species Plasmodium (P.) falciparum. The pathogenesis of CM remains poorly understood and the mechanisms involved in acquired protection against the syndrome in malaria-endemic regions are undefined. Utilising the well characterised P. berghei ANKA experimental infection model of cerebral malaria (ECM), results presented in this thesis show that the development of ECM is associated with the accumulation and arrest of pathogenic CD8+ T cells within the perivascular spaces of the brain. Accumulation of activated CD8+ T cells, without arrest, was observed in the perivascular spaces of the brains of mice infected with the non-ECM causing P. berghei NK65 strain. These data show that the behaviour of intracerebral CD8+ T cells specifies their pathogenic function during malaria infection. The development of ECM was associated with extensive disruption to the BBB, which developed in the absence of extensive CD8+ T cell-dependent endothelial cell apoptosis. We modified the ECM model, establishing an infection-drug cure strategy, to investigate the immunological basis of parasite exposure-induced resistance to ECM development. Three rounds of infection-drug cure promoted resistance to ECM, which was associated with reduced intracerebral expression of genes involved in defence response, regulation of apoptosis, chemotaxis, CTL activity, antigen processing and presentation and cell adhesion, compared with ECM susceptible mice. Additionally, CD8+ T cell activation was suppressed in exposure-induced resistant mice and was associated with the antibody dependent expansion of a splenic plasmacytoid DC population, with a regulatory phenotype. The infection-induced protection against ECM was critically dependent upon secreted antibody production. A long standing problem in studying the immune response to malaria infection has been the inability to track parasite-specific CD4+ T cell responses. To address this, we generated and validated new transgenic P. berghei parasites expressing the model antigen, ovalbumin (OVA), either in the parasite cytoplasm or on the parasitophorous vacuole membrane (PVM). We found that cellular location and expression level of the antigen influence the induction and magnitude of parasite-specific T-cell responses. These parasites thus provide knowledge on the factors that influence the recognition of parasite antigens by the immune system and represent useful tools to study the development and function of antigen-specific T-cell responses during malaria infection. The results in this thesis improve our understanding of the events that lead to the development of CM, and the host immune responses that develop following parasite exposure to protect against it. The results should contribute towards the rational development of adjunctive therapies and effective vaccines for human CM.
|
Page generated in 0.0251 seconds